14-3-3结合使帕金森相关激酶LRRK2保持在一个不活跃的状态
Juliana A Martinez Fiesco1, Alexandra Beilina2, Astrid Alvarez de la Cruz1
1Kinase Complexes Section, Center for Structural Biology, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Nature communications
|August 5, 2025
概括
14-3-3蛋白与丰富的白素重复激酶2 (LRRK2) 结合,抑制其活性,这对帕金森病 (PD) 发病至关重要. 这项研究揭示了这种相互作用的结构基础,为PD提供了新的治疗点.
科学领域:
- 结构生物学 结构生物学
- 神经科学是一个神经科学.
- 生物化学 生物化学
背景情况:
- 氨酸丰富的重复激酶2 (LRRK2) 是细胞信号传递和帕金森病 (PD) 病原体的核心.
- 14-3-3蛋白调节LRRK2活动,但它们相互作用的结构细节尚不清楚.
研究的目的:
- 阐明14-3-3蛋白抑制LRRK2活性的结构机制.
- 了解LRRK2-14-3-3相互作用在PD病变发生中的作用.
主要方法:
- 低温电子显微镜 (cryo-EM) 用于确定LRRK2:14-3-3二元复合物的结构.
- 结构导向突变发生,以评估PD相关突变对结合和活性的影响.
- 生物化学试验评估酶抑制剂对14-3-3结合和酸化的影响.
主要成果:
- 冷-EM结构显示了一个14-3-3二元体,通过双位点定稳定了一个自我抑制的LRRK2单元体.
- 这种相互作用涉及化S910/S935位点和Roc-COR GTPase区域,限制LRRK2.
- 接口上的PD相关突变会削弱14-3-3结合并损害抑制;激酶抑制剂会破坏这种相互作用.
结论:
- 这项研究为14-3-3蛋白对LRRK2自身抑制提供了结构基础.
- 这说明了14-3-3在LRRK2调节和PD中的机械作用.
- 研究结果表明,针对LRRK2-14-3-3相互作用的治疗策略可用于PD治疗.
相关概念视频
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Amplifying Signals via Enzymatic Cascade
8.8K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.8K
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Protein Kinases and Phosphatases
13.4K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.4K
Receptor Tyrosine Kinases
14.1K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
14.1K


